Cargando…
Designing and evaluating contextualized drug–drug interaction algorithms
OBJECTIVE: Alert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug–drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient’s clinical situation. Existing alerting systems for DDIs are often simplistic in natur...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976224/ https://www.ncbi.nlm.nih.gov/pubmed/33763631 http://dx.doi.org/10.1093/jamiaopen/ooab023 |
_version_ | 1783667012869816320 |
---|---|
author | Chou, Eric Boyce, Richard D Balkan, Baran Subbian, Vignesh Romero, Andrew Hansten, Philip D Horn, John R Gephart, Sheila Malone, Daniel C |
author_facet | Chou, Eric Boyce, Richard D Balkan, Baran Subbian, Vignesh Romero, Andrew Hansten, Philip D Horn, John R Gephart, Sheila Malone, Daniel C |
author_sort | Chou, Eric |
collection | PubMed |
description | OBJECTIVE: Alert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug–drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient’s clinical situation. Existing alerting systems for DDIs are often simplistic in nature or do not take the specific patient context into consideration, leading to overly sensitive alerts. The objective of this study is to develop, validate, and test DDI alert algorithms that take advantage of patient context available in electronic health records (EHRs) data. METHODS: Data on the rate at which DDI alerts were triggered but for which no action was taken over a 3-month period (override rates) from a single tertiary care facility were used to identify DDIs that were considered a high-priority for contextualized alerting. A panel of DDI experts developed algorithms that incorporate drug and patient characteristics that affect the relevance of such warnings. The algorithms were then implemented as computable artifacts, validated using a synthetic health records data, and tested over retrospective data from a single urban hospital. RESULTS: Algorithms and computable knowledge artifacts were developed and validated for a total of 8 high priority DDIs. Testing on retrospective real-world data showed the potential for the algorithms to reduce alerts that interrupt clinician workflow by more than 50%. Two algorithms (citalopram/QT interval prolonging agents, and fluconazole/opioid) showed potential to filter nearly all interruptive alerts for these combinations. CONCLUSION: The 8 DDI algorithms are a step toward addressing a critical need for DDI alerts that are more specific to patient context than current commercial alerting systems. Data commonly available in EHRs can improve DDI alert specificity. |
format | Online Article Text |
id | pubmed-7976224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79762242021-03-23 Designing and evaluating contextualized drug–drug interaction algorithms Chou, Eric Boyce, Richard D Balkan, Baran Subbian, Vignesh Romero, Andrew Hansten, Philip D Horn, John R Gephart, Sheila Malone, Daniel C JAMIA Open Research and Applications OBJECTIVE: Alert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug–drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient’s clinical situation. Existing alerting systems for DDIs are often simplistic in nature or do not take the specific patient context into consideration, leading to overly sensitive alerts. The objective of this study is to develop, validate, and test DDI alert algorithms that take advantage of patient context available in electronic health records (EHRs) data. METHODS: Data on the rate at which DDI alerts were triggered but for which no action was taken over a 3-month period (override rates) from a single tertiary care facility were used to identify DDIs that were considered a high-priority for contextualized alerting. A panel of DDI experts developed algorithms that incorporate drug and patient characteristics that affect the relevance of such warnings. The algorithms were then implemented as computable artifacts, validated using a synthetic health records data, and tested over retrospective data from a single urban hospital. RESULTS: Algorithms and computable knowledge artifacts were developed and validated for a total of 8 high priority DDIs. Testing on retrospective real-world data showed the potential for the algorithms to reduce alerts that interrupt clinician workflow by more than 50%. Two algorithms (citalopram/QT interval prolonging agents, and fluconazole/opioid) showed potential to filter nearly all interruptive alerts for these combinations. CONCLUSION: The 8 DDI algorithms are a step toward addressing a critical need for DDI alerts that are more specific to patient context than current commercial alerting systems. Data commonly available in EHRs can improve DDI alert specificity. Oxford University Press 2021-03-19 /pmc/articles/PMC7976224/ /pubmed/33763631 http://dx.doi.org/10.1093/jamiaopen/ooab023 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research and Applications Chou, Eric Boyce, Richard D Balkan, Baran Subbian, Vignesh Romero, Andrew Hansten, Philip D Horn, John R Gephart, Sheila Malone, Daniel C Designing and evaluating contextualized drug–drug interaction algorithms |
title | Designing and evaluating contextualized drug–drug interaction algorithms |
title_full | Designing and evaluating contextualized drug–drug interaction algorithms |
title_fullStr | Designing and evaluating contextualized drug–drug interaction algorithms |
title_full_unstemmed | Designing and evaluating contextualized drug–drug interaction algorithms |
title_short | Designing and evaluating contextualized drug–drug interaction algorithms |
title_sort | designing and evaluating contextualized drug–drug interaction algorithms |
topic | Research and Applications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976224/ https://www.ncbi.nlm.nih.gov/pubmed/33763631 http://dx.doi.org/10.1093/jamiaopen/ooab023 |
work_keys_str_mv | AT choueric designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT boycerichardd designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT balkanbaran designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT subbianvignesh designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT romeroandrew designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT hanstenphilipd designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT hornjohnr designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT gephartsheila designingandevaluatingcontextualizeddrugdruginteractionalgorithms AT malonedanielc designingandevaluatingcontextualizeddrugdruginteractionalgorithms |